Literature DB >> 14927798

The lysis in rabbits of intravascular blood clots by the streptococcal fibrinolytic system (streptokinase).

A J JOHNSON, W S TILLETT.   

Abstract

1. Based upon quantitative estimations of the factors that promote or retard the development and activity of the streptococcal fibrinolytic phenomenon, an active lytic system was developed within the circulating blood stream of rabbits following the intravenous infusion of streptokinase. During the infusion of adequate doses of SK, an active lytic system was observed to be present within 30 minutes following the beginning of the experiment and remained present for periods of time ranging from 1 to 20 hours depending primarily upon the concentration of SK and the duration of the infusion. Some of the biochemical changes accompanying the lytic system in vivo were: (a) a striking fall in the plasminogen; (b) a moderate fall in the serum inhibitor and the fibrinogen; and, (c) a rise in the acid-soluble nitrogen. These changes were usually self-terminating within 24 hours following the infusion of SK. In earlier studies similar trends were observed in the chest fluid of patients with hemothorax and empyema treated locally with streptokinase (22). 2. Intravascular clots, induced artificially by local applications of sodium morrhuate within the ear vein of the rabbits, were observed to liquefy and disappear in 23 of 25 rabbits during the intravenous infusion of SK into the opposite ear. The average quantity of SK necessary to effect an active lytic system was found to be about 40,000 units per kilo per hour. The clot in the ear vein was observed to be lysed completely in periods of time ranging from 3 to 7 hours after the infusion of SK was begun. Maintenance of an active lytic system for 3 to 4 additional hours was required to prevent re-formation of the clots at the original site. In 3 of 4 rabbits in which clots did reform, ACTH had been given to combat the toxic effects of the streptococcal concentrates. 3. The toxicity of the unusually large dose of the streptococcal concentrates, containing measured amounts of SK, along with other identifiable and unknown substances, was considerable, inasmuch as 8 animals eventually died. No evidence of pulmonary infarction was observed at autopsy. The administration of ACTH appeared to prevent a fatal outcome in at least 3 of the rabbits. Further studies of toxicity are in progress.

Entities:  

Keywords:  STREPTOMYCIN/effects; THROMBOSIS/experimental

Mesh:

Substances:

Year:  1952        PMID: 14927798      PMCID: PMC2212084          DOI: 10.1084/jem.95.5.449

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  6 in total

1.  A STUDY OF ANTIFIBRINOLYSIN ACTIVITY IN THE PLASMAS OF VARIOUS ANIMAL SPECIES.

Authors:  M M Guest; B M Daly; A G Ware; W H Seegers
Journal:  J Clin Invest       Date:  1948-11       Impact factor: 14.808

2.  THE EFFECT IN PATIENTS OF STREPTOCOCCAL FIBRINOLYSIN (STREPTOKINASE) AND STREPTOCOCCAL DESOXYRIBONUCLEASE ON FIBRINOUS, PURULENT, AND SANGUINOUS PLEURAL EXUDATIONS.

Authors:  W S Tillett; S Sherry
Journal:  J Clin Invest       Date:  1949-01       Impact factor: 14.808

3.  QUANTITATIVE MICRO-ESTIMATION OF ANTIBODIES IN THE SERA OF MAN AND OTHER ANIMALS.

Authors:  M Heidelberger; C F Macpherson
Journal:  Science       Date:  1943-04-30       Impact factor: 47.728

4.  Hypercoagulability of the blood associated with ACTH and cortisone therapy.

Authors:  S W COSGRIFF; A F DIEFENBACH; W VOGT
Journal:  Am J Med       Date:  1950-12       Impact factor: 4.965

5.  The use of streptokinase-streptodornase in the treatment of hemothorax.

Authors:  S SHERRY; W S TILLETT; C T READ
Journal:  J Thorac Surg       Date:  1950-09

6.  Effects of intravenous injection in dogs of staphylokinase and dog serum fibrinolysin.

Authors:  J H LEWIS; J H FERGUSON
Journal:  Proc Soc Exp Biol Med       Date:  1949-08
  6 in total
  33 in total

1.  The Emergence of Thrombocardiology.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1994       Impact factor: 2.300

2.  Cardiology's 10 greatest discoveries of the 20th century.

Authors:  Nirav J Mehta; Ijaz A Khan
Journal:  Tex Heart Inst J       Date:  2002

3.  [IN VITRO STUDIES ON THE PROBLEM OF FIBRINOLYSIS AND THROMBOLYSIS WITH STREPTOKINASE].

Authors:  H W SCHMIDT
Journal:  Klin Wochenschr       Date:  1963-10-15

4.  Studies on fibrinolysis inhibitors of the serum contacted with globulin activated with streptokinase.

Authors:  G D GIACOMAZZI
Journal:  Blut       Date:  1962-10

5.  Thrombolytic therapy.

Authors:  G P MCNICOL
Journal:  Proc R Soc Med       Date:  1963-05

6.  Feasibility of adequate thrombolytic therapy with streptokinase in peripheral arterial occlusions. I. Clinical and arteriographic results.

Authors:  M VERSTRAETE; A AMERY; J VERMYLEN
Journal:  Br Med J       Date:  1963-06-08

7.  Structural units of human 7S gamma globulin.

Authors:  E C FRANKLIN
Journal:  J Clin Invest       Date:  1960-12       Impact factor: 14.808

8.  [Lysis of human blood clots in vitro].

Authors:  H ROSOLLECK
Journal:  Klin Wochenschr       Date:  1961-04-15

9.  The mechanism of clot dissolution by plasmin.

Authors:  N ALKJAERSIG; A P FLETCHER; S SHERRY
Journal:  J Clin Invest       Date:  1959-07       Impact factor: 14.808

10.  The maintenance of a sustained thrombolytic state in man. I. Induction and effects.

Authors:  A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1959-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.